ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2011

Assessment of Methods to Quantitatively Evaluate Global Synovitis Activity with FDG-PET/CT

William Y. Raynor1, Venkata S. Jonnakuti1, Kaiyuan Zheng1, Poul Flemming Høilund-Carlsen2, Abass Alavi3 and Joshua Baker4, 1Radiology, University of Pennsylvania, Philadelphia, PA, 2Nuclear Medicine, Odense University Hospital, Odense, Denmark, 3Department of Radiology/Division of Nuclear Medicine, University of Pennsylvania, Philadelphia, PA, 4Rheumatology, University of Pennsylvania, Philadelphia, PA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Imaging, positron emission tomography (PET) and synovitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Imaging of Rheumatic Diseases Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Fluorodeoxyglucose (FDG)-positron emission tomography (PET) allows more direct assessment of inflammation than other imaging modalities by portraying metabolic activity. No standards exist for objective quantification of joint activity using PET, and many techniques rely on subjective initial assessments and use of a sample of voxels such as SUVmax or SUVpeak to characterize an entire region. The aim of this study was to compare the accuracy and reliability of novel methods of assessing global synovitis activity in patients with rheumatoid arthritis (RA) and healthy controls.

Methods:

FDG-PET/CT scans were performed on 19 RA patients and compared to 19 asymptomatic age- and sex-matched control subjects using similar acquisition methods. Several methods of quantification were performed. Method A used a traditional subjective approach to only measure ÒactiveÓ joints and an adaptive thresholding algorithm with a lower threshold defined as 40% of the SUVmax in selected joints. Methods B utilized the average SUVmax in control subjects as a lower threshold to exclude only the expected background uptake (separately for each joint type). For both methods, the sum of the partial volume-corrected mean metabolic volume product (cMVPmean) for all ROIs represented the global synovitis score for each subject. RA patients were compared to controls and correlations with clinical indicators of disease activity were assessed among RA patients.

Results:

Method B demonstrated superior inter-reader reliability (r = 0.982) compared to method A (r = 0.636). Patients with RA had much higher PET global activity scores than controls regardless of method (Figure).  Method B correlated strongly with more objective clinical measures of systemic inflammation and disease activity. Method B also generally correlated more strongly with modified disease activity  (M-DAS28) scores that exclude subjective components, compared to traditional disease activity scores (Table).

Conclusion:

For quantification of synovial inflammation by PET/CT, a method of thresholding that eliminates calculated background activity is more accurate and reliable than methods that depend on the assessment of subjectively active joints using focal measurements. Further studies are needed to determine how these methods of quantification perform in longitudinal assessments to assess course of the disease and the effects of various interventions.

 

Table 1: Correlation of PET quantification methods with clinical and laboratory features of disease activity and inflammation.

 

Method A

Method B

CRP

0.16

0.41*

ESR

0.17

0.48**

Swollen Joints

0.17

0.45*

Tender Joints

0.17

0.090

Patient Global

-0.23

-0.39

Evaluator Global

-0.032

0.18

IL-6 Levels

0.073

0.56**

TNF-levels

-0.31

0.19

IL-1 levels

0.34

0.48**

 

 

 

Disease Activity

 

 

   DAS28(CRP)

0.15

0.19

   DAS28(ESR)

0.27

0.34

   M-DAS

0.076

0.42*

*p<0.10; **p<0.05


Disclosure: W. Y. Raynor, None; V. S. Jonnakuti, None; K. Zheng, None; P. F. Høilund-Carlsen, None; A. Alavi, None; J. Baker, None.

To cite this abstract in AMA style:

Raynor WY, Jonnakuti VS, Zheng K, Høilund-Carlsen PF, Alavi A, Baker J. Assessment of Methods to Quantitatively Evaluate Global Synovitis Activity with FDG-PET/CT [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/assessment-of-methods-to-quantitatively-evaluate-global-synovitis-activity-with-fdg-petct/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-methods-to-quantitatively-evaluate-global-synovitis-activity-with-fdg-petct/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology